Novo Nordisk's Wegovy gets accelerated US approval for liver disease MASH – Reuters

Written by

admin

in

  1. Novo Nordisk’s Wegovy gets accelerated US approval for liver disease MASH  Reuters
  2. Novo Nordisk announces FDA approves additional indication of Wegovy  TipRanks
  3. Wegovy® approved in the US for the treatment of MASH  drugscontrol.org
  4. Novo Nordisk wins FDA nod for Wegovy against MASH (NVO:NYSE)  Seeking Alpha
  5. Novo Nordisk’s Wegovy is first GLP-1 to break into MASH  FirstWord Pharma

Continue Reading

More posts